Shane Burgess

Shane Burgess is the co-CEO of Treadwell Therapeutics. Shane has also previously worked with VoltSafe, Hyalos Inc., and was a co-founder at FYidoctors. Shane has been working in the medical industry for over 12 years and has been instrumental in the development and success of several startups. Shane is a passionate advocate for patients and is constantly striving to improve access to quality care.

Shane Burgess has a Master of Business Administration from Simon Fraser University and a Bachelor of Science and Doctor of Optometry from the University of Waterloo.